欧盟委员会关于药物警戒的咨询。 - Suppr

European commission consultation on pharmacovigilance.

作者信息

Waller Patrick, Beard Keith, Egberts Toine, Evans Stephen, Hallas Jesper, Hasford Joerg, Laporte Joan-Ramon, Moore Nicholas, Shakir Saad, Sturkenboom Miriam

出版信息

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9. doi: 10.1002/pds.1526.

DOI:10.1002/pds.1526

PMID:18058839

Abstract

摘要

相似文献

European commission consultation on pharmacovigilance.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9. doi: 10.1002/pds.1526.

FDA attempting to overcome major roadblocks in monitoring drug safety.

J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872.

European pharmacovigilance: an overview of pharmacovigilance inspections.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):711-3. doi: 10.1002/pds.1088.

European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?

Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):339-40. doi: 10.1002/pds.622.

European drug agency criticises Roche for failing to report adverse reactions and patient deaths.

BMJ. 2012 Jun 26;344:e4344. doi: 10.1136/bmj.e4344.

Improving pharmacovigilance in Europe.

BMJ. 2010 Apr 12;340:c1694. doi: 10.1136/bmj.c1694.

European legislators tighten rules on drug safety.

BMJ. 2012 Sep 18;345:e6260. doi: 10.1136/bmj.e6260.

Points to consider: the roles of surveillance and epidemiology in advancing drug safety.

Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):665-7. doi: 10.1002/pds.1072.

Provision of information on regulatory authorities' websites.

Intern Med J. 2008 Jul;38(7):559-67. doi: 10.1111/j.1445-5994.2007.01588.x. Epub 2008 Mar 11.

Compliance in European pharmacovigilance: a regulatory view.

Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):301-2. doi: 10.1002/pds.620.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

European commission consultation on pharmacovigilance.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9. doi: 10.1002/pds.1526.

FDA attempting to overcome major roadblocks in monitoring drug safety.

J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872.

European pharmacovigilance: an overview of pharmacovigilance inspections.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):711-3. doi: 10.1002/pds.1088.

European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?

Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):339-40. doi: 10.1002/pds.622.

European drug agency criticises Roche for failing to report adverse reactions and patient deaths.

BMJ. 2012 Jun 26;344:e4344. doi: 10.1136/bmj.e4344.

Improving pharmacovigilance in Europe.

BMJ. 2010 Apr 12;340:c1694. doi: 10.1136/bmj.c1694.

European legislators tighten rules on drug safety.

BMJ. 2012 Sep 18;345:e6260. doi: 10.1136/bmj.e6260.

Points to consider: the roles of surveillance and epidemiology in advancing drug safety.

Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):665-7. doi: 10.1002/pds.1072.

Provision of information on regulatory authorities' websites.

Intern Med J. 2008 Jul;38(7):559-67. doi: 10.1111/j.1445-5994.2007.01588.x. Epub 2008 Mar 11.

Compliance in European pharmacovigilance: a regulatory view.

Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):301-2. doi: 10.1002/pds.620.

European commission consultation on pharmacovigilance.

作者信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

European commission consultation on pharmacovigilance.

作者信息

出版信息

相似文献